The DNA methylation market was valued at USD 1.29 billion in 2026 , Epigenetic information is increasingly being tapped as a means to better comprehend the mechanisms of diseases and uncover clinically relevant biomarkers. Making the DNA methylation market an exciting time of growth. The applications of these technologies are growing in cancer, neurological, developmental, and reproductive diseases. Deepa Pandey, senior research analyst, has analyzed these trends and curated this report. Her research enables companies in the fields of biotechnology, pharmaceuticals, diagnostics, healthcare, research institutions, and life sciences to understand the technological advancements, the trend of application, competitive strategies, and emerging opportunities.
